#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Uveitis Adrenoleukodystrophy Colon cancer Uterine leiomyosarcoma Candida infection Lymphatic malformation Chronic graft versus host disease in intestine Measles Philadelphia chromosome positive Hyperchylomicronaemia Leiomyosarcoma recurrent Necrotising myositis Lennox-Gastaut syndrome Blastic plasmacytoid dendritic cell neoplasia Vulval cancer recurrent More trials…

    Learn about Rare Diseases

    Anaplastic thyroid cancer – Diagnostics Antisynthetase syndrome – Trials in Disease Factor IX deficiency – Treatment Haemophilia – Basic Information Ewing’s sarcoma recurrent – Basic Information Gastrointestinal stromal tumour Pemphigoid Loeys-Dietz syndrome Pemphigus – Treatment CADASIL – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Hydroxypropylbetadex BLEXIMENIB IMB 101 Vgl101 Bay 3018250 Vedolizumab OMEGA-3-ACID ETHYL ESTERS 90 Dexamethasone Ph. Eur. Eo2318 Intestifix Levothyroxine Sodium Adg126 Resamirigene Bilparvovec Nimorazole LY3848575 Adalimumab Codeine Phosphate Ht-29-B Bleomycin Sulfate Ph. Eur. Sodium Laurilsulfate More therapies…

    Learn about Your Condition

    Rheumatic disorder Anal cancer metastatic Skin cancer Tooth loss Ehlers-Danlos syndrome Underweight Diabetes insipidus High-grade B-cell lymphoma Hepatotoxicity Lymphocytic lymphoma Anorexia nervosa Pneumonia bacterial Cerebellar ataxia Graves' disease Vertigo More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Psyon s.r.o.

Psyon s.r.o.

Cistovicka 249/11, Repy, Prague, 163 00, Czechia

Want to learn more about this study or check if you can participate? Contact us.

  • Study of deupsilocin besilate (CYB003) in adults with major depressive disorder comparing two doses against placebo

    Recruiting

    3 1
    Czechia Germany Greece Ireland Poland

  • Long-term safety and effectiveness study of CYB003 (deupsilocin besilate) with optional additional doses for people with Major Depressive Disorder

    Recruiting

    3 1 1
    Czechia Germany Greece Ireland Poland

  • Study on Psilocybin and Midazolam for Reducing Atherosclerosis in Patients with Coronary Artery Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Myocardial ischaemia
    Investigated Drugs:
    • Midazolam
    • Psilocybine
    Czechia

  • Study on the Effects of MM120 (Lysergide) for Adults with Generalized Anxiety Disorder

    Not recruiting

    3 1
    Investigated Diseases:
    • Generalised anxiety disorder
    Investigated Drugs:
    • LYSERGIDE
    Czechia France Germany Poland

  • Study on the Effects of Psilocybin (COMP360) for Adults with Treatment-Resistant Depression

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Psilocybine
    Czechia Denmark France Germany Ireland The Netherlands +3

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!